Baohuoside-I-Icariin-II-DataSheet-生命科学试剂-MedChemExpress_第1页
Baohuoside-I-Icariin-II-DataSheet-生命科学试剂-MedChemExpress_第2页
Baohuoside-I-Icariin-II-DataSheet-生命科学试剂-MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBaohuoside ICat. No.: HY-N0011CAS No.: 113558-15-9Synonyms: Icariin-II; Icariside-II分式: CHO分量: 514.52作靶点: CXCR; Apoptosis作通路: GPCR/G Protein; Immunology/Inflammation; Apoptosis储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6

2、months-20C 1 month溶解性数据体外实验 DMSO : 32 mg/mL (62.19 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.9436 mL 9.7178 mL 19.4356 mL5 mM 0.3887 mL 1.9436 mL 3.8871 mL10 mM 0.1944 mL 0.9718 mL 1.9436 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL A

3、CTIVITY物活性 Baohuoside I从朝鲜淫藿中得到的黄酮类化合物,作为 CXCR4 的抑制剂,能够抑制 CXCR4 的表达,诱导凋亡,具有抗肿瘤活性。IC50 & Target CXCR4 Apoptosis1/2 Master of Small Molecules 您边的抑制剂师www.MedChemE体外研究 Baohuoside I is an inhibitor of CXCR4, and downregulates CXCR4 expression at 12-25 M. Baohuoside I (0-25 M) suppresses NF-B activation i

4、n a dose-dependent manner, suppresses CXCL12 induced the invasionof cervical cancer cells. Baohuoside I also inhibits invasion of breast cancer cells 1. Baohuoside I inhibitsA549 cell viability, with IC50s of 25.1 M at 24 h, 11.5 M and 9.6 M at 48 h and 72 h, respectively.Baohuoside I (25 M) suppres

5、ses the caspase cascade in A549 cells, elevates ROS levels and activatesJNK and p38MAPK signaling cascade 2. Baohuoside I (3.125, 6.25, 12.5, 25.0 and 50.0 g/mL) significantlyand dose-dependently blocks the growth of esophageal squamous cell carcinoma Eca109 cells, with an IC50of 4.8 g/mL at 48 h 3.

6、体内研究 Baohuoside I (25 mg/kg) decreases -catenin protein levels, cyclin D1 and survivin expression in nude mice3.PROTOCOLCell Assay 2 The cytotoxicity effect of Baohuoside I on A549 cells is determined by MTT assay. Cells (1104 cells/well)are seeded in a 96-well plate, and treated with Baohuoside I (

7、6.25, 12.5, and 25 M) or 1 mM NAC for 24, 48or 72 h. After MTT containing medium is removed, the crystals that have formed are dissolved by the additionof DMSO to each well. After mixing, the absorbance of the cells is measured at 540 nm by using MultiskanSpectrum Microplate Reader 2.MCE has not ind

8、ependently confirmed the accuracy of these methods. They are for reference only.Animal Mice 3Administration 3 Female Balb/c nude mice (4- to 6-weeks-old) are used in the assay. Subconfluent Eca109-Luc cells areharvested and resuspended in PBS to a final density of 2 107 cells/mL. Prior to injection,

9、 cells areresuspended in PBS and analyzed by 0.4% trypan blue exclusion assay (viable cells 90%). Forsubcutaneous injection, 1 107 Eca109-Luc cells in 200 L PBS are injected into the left flank of eachmouse using 27G needles. At 1 week after tumor cell injection, Baohuoside I (25 mg/kg per mouse) is

10、injected intralesionally once a day, whereas the 10 mice intended for vehicle treatment are administered anequal volume of PBS 3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Kim B, et al. Baohuoside I suppresses invasion of cervical and

11、breast cancer cells through the downregulation of CXCR4 chemokinereceptor expression. Biochemistry. 2014 Dec 9;53(48):7562-9.2. Song J, et al. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 2012 Jul 30;199(1):9-17.3. Wang L, et al. The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophagealcarcinoma via -catenin-dependent signaling. Oncol Rep. 2011 Nov;26(5):1149-56.McePdfHeightCaution: Prod

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论